← All trials
NCT00929409
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2009
- Primary completion
- Jul 1, 2010
- Completion date
- Jul 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Norwegian University of Science and TechnologyLead sponsor
- Sykehuset BuskerudCollaborator
- Norwegian University of Science and TechnologyOverall official - principal investigator
- Sykehuset Innlandet HFCollaborator
- Norwegian University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.